Search

Filters

Clear Filters
3:40 PM - 3:50 PM ET

104 - Multimodal Artificial Intelligence Model for Predicting Treatment Efficacy and Optimizing Upfront Cranial Radiotherapy Selection in Third-Generation EGFR-TKI-Treated NSCLC with Brain Metastases
Speaker: Pang, Yechun - Fudan University Shanghai Cancer Center, Shanghai, DC
8:25 AM - 8:30 AM ET

1040 - Tumor-Informed Circulating Tumor DNA for Prediction of Organ Preservation and Enhanced Surveillance in Locally Advanced Rectal Cancer: A Real-World Cohort
Speaker: Ravella, Revathi, MD - Memorial Sloan Kettering Cancer Center, New York, NY
8:30 AM - 8:35 AM ET

1041 - Durability of Watch-and-Wait after Long- vs. Short-Course Radiation In Total Neoadjuvant Therapy for Rectal Cancer
Speaker: Ravella, Revathi, MD - Memorial Sloan Kettering Cancer Center, New York, NY
3:05 PM - 3:10 PM ET

1042 - Inferring the Initiation Site of Brain Necrosis from Proton Therapy via Inverse Mechanistic Modeling
Speaker: Cogno, Nicolo, PhD - Massachusetts General Hospital and Harvard Medical School, Boston, MA
3:10 PM - 3:15 PM ET

1043 - The Influence of Cancer Primary Site on Outcomes after Preoperative Radiosurgery for Resected Brain Metastases: A XXX International Multicenter Cohort Study
Speaker: Prabhu, Roshan, MD, MS - Atrium Health Levine Cancer, CHARLOTTE, NC
3:15 PM - 3:20 PM ET

1044 - Proton vs. Photon Craniospinal Irradiation for Leptomeningeal Disease: Comparative Clinical Outcomes and Acute Toxicities
Speaker: Hoang, Audi, BS - Tilman J Fertitta Family College of Medicine, Houston, TX
3:20 PM - 3:25 PM ET

1045 - Pembrolizumab and Stereotactic Radiosurgery (SRS) of Selected Brain Metastases in Breast Cancer Patients
Speaker: Gregucci, Fabiana - Weill Cornell Medical College, New York, NY
3:25 PM - 3:30 PM ET

1046 - Hematologic Toxicity, Treatment Completion Time, and Dosimetric Comparison between Proton and Photon Craniospinal Irradiation in Pediatric Tumor Patients: A Propensity Score-Matched Study
Speaker: Li, Ran, PhD - Shandong Cancer Hospital, Shandong Provincial Key Medical and Health Laboratory of Pediatric Cancer Precision Radiotherapy, Ji Nan
3:30 PM - 3:35 PM ET

1047 - Predicting Survival and Treatment Completion of Proton Craniospinal Irradiation in Leptomeningeal Disease: A Prognostic Nomogram
Speaker: Kanala, Tejaswi, MD, MBBS - MD Anderson Cancer Center, Houston, TX
3:05 PM - 3:10 PM ET

1048 - Randomized Phase II Trial of Stereotactic Body (SBRT) vs. Conventional Fractionation (CF) Radiotherapy Boost for High-Risk Prostate Cancer: Biochemical Control Outcomes of the PBS Trial
Speaker: Ben-Zvi, Libby - McMaster University, Hamilton, ON
3:00 PM - 3:10 PM ET

105 - Brachytherapy Versus External Beam Dose-Escalated Boost for Intermediate-Risk Prostate Cancer: Definitive Results of the GETUG P05 Trial
Speaker: Lapierre, Ariane, MD, PhD - Hopital Lyon Sud, Pierre Benite
3:10 PM - 3:15 PM ET

1050 - Five-Year Outcomes from a Prospective Trial of MR-Guided SBRT with Focal DIL Boost for Intermediate-Risk Prostate Cancer
Speaker: Goglia, Alexander, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY